HIV-HCV coinfection speeds HCV-related liver fibrosis

February 27, 2013
HIV-HCV coinfection speeds HCV-related liver fibrosis
Individuals who are coinfected with HIV and hepatitis C virus exhibit liver fibrosis similar to that of individuals without HIV who are nearly 10 years older, according to research published online Feb. 26 in the Annals of Internal Medicine.

(HealthDay)—Individuals who are coinfected with HIV and hepatitis C virus (HCV) exhibit liver fibrosis similar to that of individuals without HIV who are nearly 10 years older, according to research published online Feb. 26 in the Annals of Internal Medicine.

Gregory D. Kirk, M.D., M.P.H., Ph.D., of Johns Hopkins Bloomberg School of Public Health in Baltimore, and colleagues conducted a cohort study involving 1,176 current and former injection drug users with antibodies to HCV (median age, 49 years) to examine whether individuals with concurrent HIV infection develop HCV-related liver disease at younger ages than those without HIV infection.

Overall, 34 percent of participants were coinfected with HIV and HCV. Compared with patients who only had HCV, the researchers found that those who were coinfected had a significantly higher prevalence of clinically significant fibrosis without cirrhosis and of cirrhosis. Independent correlates of included increasing age and HIV infection, as well as daily alcohol use, chronic infection, greater than 25 kg/m², and elevated plasma HCV RNA levels. After accounting for these factors, HIV-infected patients exhibited liver fibrosis equal to that of people without HIV who were an average of 9.2 years older.

"In summary, persons who are coinfected with HIV and HCV have liver fibrosis stages similar to persons infected with HCV alone who are nearly one decade older," the authors write. "Additional work is needed to understand the biological basis for this observation and investigate whether effective treatment of HIV and HCV infections reduce future liver fibrosis progression."

One of the authors disclosed financial ties to the pharmaceutical industry. Support of reagents for HCV RNA testing was provided by Abbott Molecular.

Explore further: African American women with HIV/HCV less likely to die from liver disease

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

African American women with HIV/HCV less likely to die from liver disease

November 1, 2012
A new study shows that African American women coinfected with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) are less likely to die from liver disease than Caucasian or Hispanic women. Findings in the November ...

Liver stiffness predicts liver failure, cancer and mortality in cirrhotic patients

July 10, 2012
Researchers from Spain established that liver stiffness, measured by transient elastography (TE), is an independent predictor of liver failure, hepatocellular carcinoma (HCC), and mortality in cirrhotic patients coinfected ...

Severity of hepatitis C and HIV co-infection in mothers contribute to HCV transmission to child

April 27, 2011
New research shows that high maternal viral load and co-infection with human immunodeficiency virus (HIV) are the only risk factors associated with vertical transmission of the hepatitis C virus (HCV-VT). A variation in the ...

Researchers pilot new acute hepatitis C screening strategy for HIV-infected patients

October 18, 2011
Researchers at The Miriam Hospital demonstrated a practical strategy for regularly screening HIV-infected patients for acute hepatitis C virus infection (HCV), a "silent epidemic" that is rising undetected in this population ...

Recommended for you

MRSA emerged years before methicillin was even discovered

July 19, 2017
Methicillin resistant Staphylococcus aureus (MRSA) emerged long before the introduction of the antibiotic methicillin into clinical practice, according to a study published in the open access journal Genome Biology. It was ...

New test distinguishes Zika from similar viral infections

July 18, 2017
A new test is the best-to-date in differentiating Zika virus infections from infections caused by similar viruses. The antibody-based assay, developed by researchers at UC Berkeley and Humabs BioMed, a private biotechnology ...

'Superbugs' study reveals complex picture of E. coli bloodstream infections

July 18, 2017
The first large-scale genetic study of Escherichia coli (E. coli) cultured from patients with bloodstream infections in England showed that drug resistant 'superbugs' are not always out-competing other strains. Research by ...

Ebola virus can persist in monkeys that survived disease, even after symptoms disappear

July 17, 2017
Ebola virus infection can be detected in rhesus monkeys that survive the disease and no longer show symptoms, according to research published by Army scientists in today's online edition of the journal Nature Microbiology. ...

Mountain gorillas have herpes virus similar to that found in humans

July 13, 2017
Scientists from the University of California, Davis, have detected a herpes virus in wild mountain gorillas that is very similar to the Epstein-Barr virus in humans, according to a study published today in the journal Scientific ...

Vaccines protect fetuses from Zika infection, mouse study shows

July 13, 2017
Zika virus causes a mild, flu-like illness in most people, but to pregnant women the dangers are potentially much worse. The virus can reduce fetal growth, cause microcephaly, an abnormally small head associated with brain ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.